Literature DB >> 843418

Comparison of the effects of labetalol and propranolol in healthy men at rest and during exercise.

D A Richards, E P Woodings, J G Maconochie.   

Abstract

1. Oral labeltalol and propranolol have been compared in healthy men with regard to the effects on heart rate, blood pressure and peak expiratory flow rate (PEFR) at rest and the changes induced by exercise. 2. Labetalol caused a dose-related reduction in standing diastolic pressure at rest whereas propranolol did not but neither drug altered standing systolic pressure at rest. 3. In the doses compared, propranolol was consistently more potent than labetalol in influencing blood pressure changes induced by exercise, in lowering heart rate at rest and reducing PEFR at rest. 4. Labetalol and propranolol are both beta-adrenoreceptor antagonists and the observed differences in the profiles of the two drugs are probably directly related to the additional alpha-adrenoreceptor blocking property of labetalol not possessed by propranolol. Because of these differences labetalol may be expected to have advantages in the treatment of hypertension.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 843418      PMCID: PMC1428991          DOI: 10.1111/j.1365-2125.1977.tb00660.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  7 in total

1.  Assessment of alpha- and beta-adrenoceptor blocking actions of labetalol.

Authors:  D A Richards; J Tuckman; B N Prichard
Journal:  Br J Clin Pharmacol       Date:  1976-10       Impact factor: 4.335

2.  Influence of metoprolol and propranolol on hemodynamic effects induced by adrenaline and physical work.

Authors:  G Johnsson
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1975

3.  Comparison of intravenous AH 5158 (ibidomide) and propranolol in asthma.

Authors:  C Skinner; J Gaddie; K N Palmer
Journal:  Br Med J       Date:  1975-04-12

4.  Letter: Intravenous labetalol in severe hypertension.

Authors:  E A Rosei; P M Trust; J J Brown; A F Lever; J I Robertson
Journal:  Lancet       Date:  1975-11-29       Impact factor: 79.321

5.  Control of heart rate by the autonomic nervous system. Studies in man on the interrelation between baroreceptor mechanisms and exercise.

Authors:  B F Robinson; S E Epstein; G D Beiser; E Braunwald
Journal:  Circ Res       Date:  1966-08       Impact factor: 17.367

6.  Beta-adrenoceptors in the human dorsal hand vein, and the effects of propranolol and practolol on venous sensitivity to noradrenaline.

Authors:  C B White; B P Udwadia
Journal:  Br J Clin Pharmacol       Date:  1975-04       Impact factor: 4.335

7.  New approach to assessment of cardioselectivity of beta-blocking drugs.

Authors:  C R Kumana; G E Marlin; C M Kaye; D M Smith
Journal:  Br Med J       Date:  1974-11-23
  7 in total
  8 in total

1.  Studies of cardioselectivity and partial agonist activity in beta-adrenoceptor blockade comparing effects on heart rate and peak expiratory flow rate during exercise.

Authors:  V M Oh; C M Kaye; S J Warrington; E A Taylor; J Wadsworth
Journal:  Br J Clin Pharmacol       Date:  1978-02       Impact factor: 4.335

Review 2.  Labetalol: a review of its pharmacology and therapeutic use in hypertension.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1978-04       Impact factor: 9.546

3.  Beta-blocking and electrophysiological effects of propafenone in volunteers.

Authors:  H Müller-Peltzer; G Greger; G Neugebauer; M Hollmann
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

Review 4.  Clinical pharmacology of labetalol.

Authors:  D A Richards; B N Prichard
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

5.  Comparison of labetalol, propranolol and hydralazine in hypertensive out-patients.

Authors:  E van der Veur; B S ten Berge; A J Donker; J F May; H Wesseling
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

6.  Effect of indoramin, labetalol and alinidine on sympathetic function in normal man.

Authors:  D P Nicholls; J McNeill; P C O'Connor; D W Harron; W J Leahey; R G Shanks
Journal:  Br J Clin Pharmacol       Date:  1984-08       Impact factor: 4.335

7.  Bronchial and cardiac beta-adrenoceptor blockade--a comparison of atenolol, acebutolol and labetalol.

Authors:  H R Gribbin; A D Mackay; C J Baldwin; A E Tattersfield
Journal:  Br J Clin Pharmacol       Date:  1981-07       Impact factor: 4.335

8.  Erythrocyte G protein as a novel target for malarial chemotherapy.

Authors:  Sean C Murphy; Travis Harrison; Heidi E Hamm; Jon W Lomasney; Narla Mohandas; Kasturi Haldar
Journal:  PLoS Med       Date:  2006-12       Impact factor: 11.069

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.